🟢 Top news - March 2022

Welcome new members!

Videointerviews

Mimark, new member!

Marina Rigau, CEO & Co-Founder
Eva Colàs, CSO & Co-Founder

See on YouTube


News

CataloniaBio & HealthTech celebrates the milestone of 200 members with excitement and optimism, in the annual meeting of the sector

An atmosphere of optimism about the situation of the sector has been present in the celebration of the Night of CataloniaBio & Healthtech, the annual meeting of the health and life sciences sector in Catalonia, which was held this March 22 at the Palau de la Música in Barcelona. The event was attended by the Catalan Minister of Health, Josep Maria Argimon, and more than 250 members of the association, including entrepreneurs, executives, and investors in the sector.

Read | Photo Gallery

IMIDomics wins the 2021 Biosuccess Award from CataloniaBio & HealthTech

CataloniaBio & HealthTech has awarded the biotech company IMIDomics with the Bioèxit Award for the exemplary translation from the clinic to the business world and, in particular, for the milestones achieved in funding during 2021 in the  field of biomedicine and health in Catalonia. The jury has especially valued the ability to raise international funds during  2021. They received the award from the Minister of Health of the Generalitat de Catalunya, Josep Maria Argimon, during the CataloniaBio & HealthTech Gala.

Read|Photo Gallery

Joan Puig, CEO of Kymos, new president of CataloniaBio & HealthTech

Read

A personalised Mobile World Congress for CataloniaBio & HealthTech companies

Read

Devshealth and FLSida start a joint project to develop new COVID-19 treatments

Read

MOWOOT obtains €1M in the first part of its investment round after obtaining the European patent

Read

Statement in support of Ukraine and the Ukranian people in the face of Russia's invasion

Read

GENOMCORE receives nearly €1M from NextGenEu for AI in customizing metastatic cancer treatment

Read

Asabys Partners joins the EIF and raises its first Fund to 117 million

Read

GoodGut and Vall d'Hebron study implementation of first non-invasive diagnostic test for IBS

Read

Vytrus Biotech is up more than 25% in its stock market debut at BME Growth

Read

Ysios Capital strengthens its team with the appointment of ThomasHarth as Principal

Read

Inveready is growing in the asset management business with the acquisition of True Value

Read

Integra Therapeutics appoints recognized geneticist George Church to its Scientific Advisory Board

Read

Creatio receives funding to acquire a 4D bioprinter

Read

Specipig closes 2021 with 150 biomedical research projects

Read

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

Read

DyCare closes a €1.3 million round from European funds

Read

IBEC will lead the state's largest health biotechnology consortium

Read

Job Offers

BECOME A MEMBER